{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:28:44Z","timestamp":1787668124815,"version":"build-2736575974"},"reference-count":25,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Immunohistochemistry-based assessment of human epidermal growth factor receptor 2 (HER2) is increasingly useful for clinical decision-making in breast, gastroesophageal, and other cancers. Retroactive use of cancer tissue for research purposes is increasing alongside increased understanding of HER2\u2019s role in determining cancer outcomes. Best practices for formalin-fixed, paraffin-embedded (FFPE) tissue handling are addressed in guidelines for diagnostic and scientific activities; however, preanalytic variables arising after tissue embedding and sectioning are minimally discussed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To quantify the loss of HER2 antigenicity that occurs on sectioned FFPE slides over long- and short-term timescales, in both room-temperature and freezer conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>\n                      Surplus FFPE microarray slides from years-prior experiments, stored either at room temperature or in a \u221280\u00b0C freezer, were paired with block-matched, freshly cut slides for analysis of postsectioning epitope degradation. To evaluate short-term changes in epitope availability, a set of FFPE slides was serially stained by immunofluorescence during a 2-month period, using standardization to mass spectrometry values to enable standardized quantification of antigen in amol (attomoles)\/mm\n                      <jats:sup>2<\/jats:sup>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>Significant degradation of HER2 antigen on FFPE slides occurs over a period of years when slides are stored at room temperature, but not when stored at \u221280\u00b0C. In either condition, the amount of degradation that occurs within a 2-month timescale is negligible compared to variation attributable to tumor heterogeneity and interrun variability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Room-temperature storage of FFPE slides appears to be safe for HER2 measurement when staining will occur within 2 months. The \u201cshelf life\u201d of slides stored at \u221280\u00b0C is at least 1 year.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2025-0447-oa","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:35:36Z","timestamp":1776472536000},"page":"707-712","source":"Crossref","is-referenced-by-count":0,"title":["Temperature-Dependent Long-term and Short-term Stability of Human Epidermal Growth Factor Receptor 2 Antigenicity on Pathology Slides"],"prefix":"10.5858","volume":"150","author":[{"given":"Liam","family":"Scott","sequence":"first","affiliation":[{"name":"From the Department of Pathology, Yale School of Medicine, New Haven, Connecticut (Scott, Benanto, Robbins, Bates, He, Chan, Rimm)"},{"name":"the Department of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, Kentucky (Scott)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Benanto","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Yale School of Medicine, New Haven, Connecticut (Scott, Benanto, Robbins, Bates, He, Chan, Rimm)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Robbins","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Yale School of Medicine, New Haven, Connecticut (Scott, Benanto, Robbins, Bates, He, Chan, Rimm)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Bates","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Yale School of Medicine, New Haven, Connecticut (Scott, Benanto, Robbins, Bates, He, Chan, Rimm)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengni","family":"He","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Yale School of Medicine, New Haven, Connecticut (Scott, Benanto, Robbins, Bates, He, Chan, Rimm)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nay Nwe Nyein","family":"Chan","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Yale School of Medicine, New Haven, Connecticut (Scott, Benanto, Robbins, Bates, He, Chan, Rimm)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Rimm","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Yale School of Medicine, New Haven, Connecticut (Scott, Benanto, Robbins, Bates, He, Chan, Rimm)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"issue":"16","key":"i1543-2165-150-9-707-b01","series-title":"J Clin Oncol","first-page":"2784","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","unstructured":"Hammond ME,Hayes DF,Dowsett M, et al. American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28(16):2784\u20132795. doi:10.1200\/jco.2009.25.6529"},{"issue":"9","key":"i1543-2165-150-9-707-b02","series-title":"Arch Pathol Lab Med","first-page":"993","article-title":"Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology\u2013College of American Pathologists Guideline Update","volume":"147","author":"Wolff","year":"2023","unstructured":"Wolff AC,Somerfield MR,Dowsett M, et al. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology\u2013College of American Pathologists Guideline Update. Arch Pathol Lab Med. 2023;147(9):993\u20131000. doi:10.5858\/arpa.2023-0950-SA"},{"issue":"23","key":"i1543-2165-150-9-707-b03","series-title":"J Natl Cancer Inst","first-page":"1815","article-title":"Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues","volume":"104","author":"Neumeister","year":"2012","unstructured":"Neumeister VM,Anagnostou V,Siddiqui S, et al. Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues. J Natl Cancer Inst. 2012;104(23):1815\u20131824. doi:10.1093\/jnci\/djs438"},{"issue":"1","key":"i1543-2165-150-9-707-b04","series-title":"Mod Pathol","first-page":"1","article-title":"Delay to formalin fixation \u2018cold ischemia time\u2019: effect on ERBB2 detection by in-situ hybridization and immunohistochemistry","volume":"26","author":"Portier","year":"2013","unstructured":"Portier BP,Wang Z,Downs-Kelly E, et al. Delay to formalin fixation \u2018cold ischemia time\u2019: effect on ERBB2 detection by in-situ hybridization and immunohistochemistry. Mod Pathol. 2013;26(1):1\u20139. doi:10.1038\/modpathol.2012.123"},{"issue":"3","key":"i1543-2165-150-9-707-b05","series-title":"Lab Invest","first-page":"334","article-title":"Preanalytical variables and phosphoepitope expression in FFPE tissue: quantitative epitope assessment after variable cold ischemic time","volume":"95","author":"Vassilakopoulou","year":"2015","unstructured":"Vassilakopoulou M,Parisi F,Siddiqui S, et al. Preanalytical variables and phosphoepitope expression in FFPE tissue: quantitative epitope assessment after variable cold ischemic time. Lab Invest. 2015;95(3):334\u2013341. doi:10.1038\/labinvest.2014.139"},{"issue":"8","key":"i1543-2165-150-9-707-b06","series-title":"Mod Pathol","first-page":"1098","article-title":"The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma","volume":"25","author":"Yildiz-Aktas","year":"2012","unstructured":"Yildiz-Aktas IZ,Dabbs DJ,Bhargava R. The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma. Mod Pathol. 2012;25(8):1098\u20131105. doi:10.1038\/modpathol.2012.59"},{"issue":"5","key":"i1543-2165-150-9-707-b07","series-title":"J Clin Pathol","first-page":"370","article-title":"Variability of immunohistochemical reactivity on stored paraffin slides","volume":"51","author":"Bertheau","year":"1998","unstructured":"Bertheau P,Cazals-Hatem D,Meignin V, et al. Variability of immunohistochemical reactivity on stored paraffin slides. J Clin Pathol. 1998;51(5):370\u2013374. doi:10.1136\/jcp.51.5.370"},{"issue":"3","key":"i1543-2165-150-9-707-b08","series-title":"Appl Immunohistochem Mol Morphol","first-page":"221","article-title":"Decline in antigenicity of tumor markers by storage time using pathology sections cut from tissue microarrays","volume":"24","author":"Blows","year":"2016","unstructured":"Blows FM,Ali HR,Dawson SJ, et al. Decline in antigenicity of tumor markers by storage time using pathology sections cut from tissue microarrays. Appl Immunohistochem Mol Morphol. 2016;24(3):221\u2013226. doi:10.1097\/pai.0000000000000172"},{"issue":"8","key":"i1543-2165-150-9-707-b09","series-title":"Lab Invest","first-page":"1071","article-title":"Long-term preservation of antigenicity on tissue microarrays","volume":"84","author":"DiVito","year":"2004","unstructured":"DiVito KA,Charette LA,Rimm DL,Camp RL. Long-term preservation of antigenicity on tissue microarrays. Lab Invest. 2004;84(8):1071\u20131078. doi:10.1038\/labinvest.3700131"},{"issue":"1","key":"i1543-2165-150-9-707-b10","series-title":"Clin Transl Med","first-page":"4","article-title":"Proper paraffin slide storage is crucial for translational research projects involving immunohistochemistry stains","volume":"3","author":"Economou","year":"2014","unstructured":"Economou M,Sch\u00f6ni L,Hammer C,Galv\u00e1n JA,Mueller DE,Zlobec I. Proper paraffin slide storage is crucial for translational research projects involving immunohistochemistry stains. Clin Transl Med. 2014;3(1):4. doi:10.1186\/2001-1326-3-4"},{"issue":"6","key":"i1543-2165-150-9-707-b11","series-title":"Lab Invest","first-page":"874","article-title":"Accelerated instability testing reveals quantitative mass spectrometry overcomes specimen storage limitations associated with PD-L1 immunohistochemistry","volume":"100","author":"Haragan","year":"2020","unstructured":"Haragan A,Liebler DC,Das DM, et al. Accelerated instability testing reveals quantitative mass spectrometry overcomes specimen storage limitations associated with PD-L1 immunohistochemistry. Lab Invest. 2020;100(6):874\u2013886. doi:10.1038\/s41374-019-0366-y"},{"issue":"1","key":"i1543-2165-150-9-707-b12","series-title":"Vet Pathol","first-page":"102","article-title":"Immunohistochemical evaluation of the effects of paraffin section storage on biomarker stability","volume":"51","author":"Ramos-Vara","year":"2014","unstructured":"Ramos-Vara JA,Webster JD,DuSold D,Miller MA. Immunohistochemical evaluation of the effects of paraffin section storage on biomarker stability. Vet Pathol. 2014;51(1):102\u2013109. doi:10.1177\/0300985813476067"},{"issue":"11","key":"i1543-2165-150-9-707-b13","series-title":"Lancet Glob Health","first-page":"e1553","article-title":"Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys","volume":"9","author":"Yadav","year":"2021","unstructured":"Yadav H,Shah D,Sayed S,Horton S,Schroeder LF. Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys. Lancet Glob Health. 2021;9(11):e1553\u2013e1560. doi:10.1016\/S2214-109X(21)00442-3"},{"key":"i1543-2165-150-9-707-b14","series-title":"Breast","first-page":"S3","article-title":"Global challenges in breast cancer detection and treatment","volume":"62","author":"Barrios","year":"2022","unstructured":"Barrios CH. Global challenges in breast cancer detection and treatment. Breast. 2022;62:S3\u2013S6. doi:10.1016\/j.breast.2022.02.003"},{"issue":"4","key":"i1543-2165-150-9-707-b15","series-title":"J Histochem Cytochem","first-page":"356","article-title":"Factors influencing the degradation of archival formalin-fixed paraffin-embedded tissue sections","volume":"59","author":"Xie","year":"2011","unstructured":"Xie R,Chung J-Y,Ylaya K, et al. Factors influencing the degradation of archival formalin-fixed paraffin-embedded tissue sections. J Histochem Cytochem . 2011;59(4):356\u2013365. doi:10.1369\/0022155411398488"},{"issue":"1","key":"i1543-2165-150-9-707-b16","series-title":"Virchows Archiv","first-page":"3","article-title":"Standardized pathology report for HER2 testing in compliance with 2023 ASCO\/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer","volume":"484","author":"Ivanova","year":"2024","unstructured":"Ivanova M,Porta FM,D\u2019Ercole M, et al. Standardized pathology report for HER2 testing in compliance with 2023 ASCO\/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer. Virchows Archiv. 2024;484(1):3\u201314. doi:10.1007\/s00428-023-03656-w"},{"issue":"10","key":"i1543-2165-150-9-707-b17","series-title":"Lab Invest","first-page":"1101","article-title":"Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer","volume":"102","author":"Moutafi","year":"2022","unstructured":"Moutafi M,Robbins CJ,Yaghoobi V, et al. Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer. Lab Invest. 2022;102(10):1101\u20131108. doi:10.1038\/s41374-022-00804-9"},{"issue":"9","key":"i1543-2165-150-9-707-b18","series-title":"Mod Pathol","first-page":"100556","article-title":"Quantitative measurement of HER2 expression in non-small cell lung cancer with a high-sensitivity assay","volume":"37","author":"Liu","year":"2024","unstructured":"Liu M,Vathiotis I,Robbins CJ, et al. Quantitative measurement of HER2 expression in non-small cell lung cancer with a high-sensitivity assay. Mod Pathol. 2024;37(9):100556. doi:10.1016\/j.modpat.2024.100556"},{"key":"i1543-2165-150-9-707-b19","series-title":"Lab Invest","first-page":"104233","article-title":"Validation and prospective testing of a high sensitivity, quantitative analytic assay for HER2 on histopathology slides","author":"Chan","year":"2025","unstructured":"Chan NNN,Gaule P,Benanto J, et al. Validation and prospective testing of a high sensitivity, quantitative analytic assay for HER2 on histopathology slides. Lab Invest. 2025:104233. doi:10.1016\/j.labinv.2025.104233"},{"issue":"1","key":"i1543-2165-150-9-707-b20","series-title":"Sci Rep","first-page":"16878","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","unstructured":"Bankhead P,Loughrey MB,Fern\u00e1ndez JA, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7(1):16878. doi:10.1038\/s41598-017-17204-5"},{"issue":"9","key":"i1543-2165-150-9-707-b21","series-title":"JCO Precis Oncol","first-page":"e2500128","article-title":"Quantitative multiplex immunofluorescence assay for trophoblast cell-surface antigen 2 and human epidermal growth factor receptor 2 expression in breast cancer: toward guiding patient selection for antibody-drug conjugate therapies","author":"Robbins","year":"2025","unstructured":"Robbins CJ,He M,Chan N, et al. Quantitative multiplex immunofluorescence assay for trophoblast cell-surface antigen 2 and human epidermal growth factor receptor 2 expression in breast cancer: toward guiding patient selection for antibody-drug conjugate therapies. JCO Precis Oncol. 2025;(9):e2500128. doi:10.1200\/po-25-00128"},{"key":"i1543-2165-150-9-707-b22","article-title":"GitHub","author":"Qymia in QuPath","unstructured":"Qymia in QuPath. GitHub. https:\/\/github.com\/snibbor\/Qymia-in-QuPath\/tree\/main. Accessed February 1, 2026."},{"issue":"6","key":"i1543-2165-150-9-707-b23","series-title":"Pathol Int","first-page":"313","article-title":"The assessment of HER2 status in breast cancer: the past, the present, and the future","volume":"66","author":"Nitta","year":"2016","unstructured":"Nitta H,Kelly BD,Allred C, et al. The assessment of HER2 status in breast cancer: the past, the present, and the future. Pathol Int. 2016;66(6):313\u2013324.doi:10.1111\/pin.12407"},{"issue":"3","key":"i1543-2165-150-9-707-b24","series-title":"Lab Invest","first-page":"264","article-title":"Loss of antigenicity with tissue age in breast cancer","volume":"96","author":"Combs","year":"2016","unstructured":"Combs SE,Han G,Mani N,Beruti S,Nerenberg M,Rimm DL. Loss of antigenicity with tissue age in breast cancer. Lab Invest. 2016;96(3):264\u2013269. doi:10.1038\/labinvest.2015.138"},{"issue":"7","key":"i1543-2165-150-9-707-b25","series-title":"Mod Pathol","first-page":"100159","article-title":"Tissue age affects antigenicity and scoring for the 22C3 immunohistochemistry companion diagnostic test","volume":"36","author":"Fernandez","year":"2023","unstructured":"Fernandez AI,Gaule P,Rimm DL. Tissue age affects antigenicity and scoring for the 22C3 immunohistochemistry companion diagnostic test. Mod Pathol. 2023;36(7):100159.doi:10.1016\/j.modpat.2023.100159"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/150\/9\/article-p707.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/150\/9\/article-p707.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/150\/9\/article-p707.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:49:54Z","timestamp":1787665794000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/150\/9\/article-p707.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":25,"journal-issue":{"issue":"9"},"URL":"https:\/\/doi.org\/10.5858\/arpa.2025-0447-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}